B, Sept. 28, 2017 -- Marine Corps General John “Jay” Paxton Jr. (Ret) has joined the Council of Directors of The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF).
|
||||||||
He served as the 33rd Assistant Commandant of the Marine Corps before retiring in 2016. As the second-highest ranking officer in the Marine Corps, he played a critical role in ensuring the health and wellbeing of Marines. With deployments to locations worldwide, he emphasized, advocated and recommended priorities for the Marine Corps.
“General Paxton is an incredibly accomplished individual with a genuine commitment to the health and readiness of America’s fighting force,” said Philip Odeen, chairman of HJF’s Council of Directors. “We are very fortunate in bringing his expertise and experience to our board. He is a most welcome addition.”
General Paxton received the Hero of Military Medicine Senior Leader Award from HJF in 2016 for his commitment to delivering world-class medical care to Marines and for his extraordinary contribution to improving the lives of U.S. service members, veterans and their families. General Paxton’s wife, Debbie Paxton, R.N., M.S.N., F.N.P., was honored with a Hero of Military Medicine Civilian Award in 2015 for her work as mental health advisor to the U.S. Marine Corps Wounded Warrior Regiment, where she engaged the military and civilian medical communities in the treatment of traumatic brain injury and posttraumatic stress. The Hero of Military Medicine Awards are presented each May by HJF and its Center for Public-Private Partnerships.
The Foundation, a private, not-for-profit organization, serves its mission of advancing research and education at the Uniformed Services University of the Health Sciences and throughout the military medical community.
It offers services that allow military researchers and clinicians to maintain their scientific focus and accomplish their research goals. HJF recruits staff, establishes and manages laboratories and research programs, administers clinical trials, and facilitates the transfer of technology to the private sector.
HJF supports hundreds of research projects, ranging from small bench-top projects to complex, multi-site programs. Its extensive research portfolio includes cancer, combat casualty care, infectious disease and precision medicine. One of its most important roles is facilitating clinical trials of vaccines for diseases that can affect our service members, including HIV, malaria and Ebola.
* * *
About HJF
HJF is one of the largest private, not-for-profit organizations in the Washington, D.C. area. It was established in 1983 and authorized by the U.S. Congress to support medical research and education at the Uniformed Services University of the Health Sciences and throughout the military community. The Foundation is headquartered in Bethesda, Maryland, but operates across the U.S. and internationally. www.hjf.org.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/38944c15-6fe1-4183-9d1a-e8b187276a7e
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2c4f7308-79a5-446d-b8c7-b6e2ff52c696
JoAnn Sperber Henry M. Jackson Foundation for the Advancement of Military Medicine 240-694-2163 [email protected]


Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
OpenAI Addresses Security Vulnerability in macOS App Certification Process
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions 



